Adaptyx provides a wearable dermal patch that continuously samples interstitial fluid and uses programmable molecular switches to deliver lab‑grade biochemical data in real time. Integrated AI analyzes the streaming biomarker feed to identify trends and trigger alerts, enabling clinicians to make timely, proactive treatment decisions without repeated venipuncture or clinic visits.
Funding
$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
7OICFounders
Product
Problem
Current clinical practice relies on intermittent lab draws and clinic visits, providing only snapshot measurements of hormones, glucose, drug levels, and other biomarkers. This low-frequency data can miss rapid physiological changes, delaying detection of critical events and limiting proactive disease management.
Solution
Adaptyx offers a wearable dermal patch that continuously samples interstitial fluid and uses programmable molecular switches to detect a wide range of biomarkers in real time. The patch’s advanced electronics convert molecular binding events into digital signals, creating a streaming dataset rather than isolated test results. Integrated AI algorithms analyze the continuous data feed, identifying trends and inflection points that inform timely clinical interventions. By delivering laboratory‑grade biochemical information continuously, the platform enables precision drug dosing, early complication detection, and proactive care without the need for repeated venipuncture or clinic appointments.
Target Audience
Primary customers are healthcare providers and health systems seeking continuous biochemical monitoring for chronic disease management, post‑surgical care, and precision pharmacotherapy, as well as pharmaceutical companies developing closed‑loop drug delivery solutions.
Features
- Minimally‑invasive, lightweight wearable patch that continuously samples interstitial fluid
- Proprietary synthetic DNA molecular switches programmable to detect metabolites, drugs, electrolytes, proteins, and hormones
- Real‑time signal conversion via on‑patch electronics for immediate digital data output
- AI‑driven analytics engine that processes streaming biomarker data to reveal trends and trigger alerts
- Robust performance in complex biological matrices with resistance to biofouling and stability for weeks
- Modular design allowing detection ranges from picomolar to millimolar concentrations
- High‑throughput Switch Foundry accelerates sensor development from years to weeks using automated engineering, parallel screening, and AI‑assisted design